Asthma in Australia 2008 
Table A1.8
Classification of respiratory medications
| Category | Medications included |
DDDs/formulation
|
|---|---|---|
| Short–acting beta–agonists | Fenoterol | 0.6 mg Inhalation aerosol |
0.6 mg Inhalation powder |
||
4 mg Inhalation solution |
||
| Orciprenaline | 60 mg Oral |
|
| Salbutamol | 0.8 mg Inhalation aerosol |
|
0.8 mg Inhalation powder |
||
10 mg Inhalation solution |
||
| Terbutaline | 2 mg Inhalation aerosol |
|
2 mg Inhalation powder |
||
20 mg Inhalation solution |
||
| Long–acting beta–agonists | Salmeterol | 0.1 mg Inhalation aerosol |
0.1 mg Inhalation powder |
||
| (e)Formoterol | 24 mcg Inhalation aerosol |
|
24 mcg Inhalation powder |
||
| Short–acting anti–cholinergics | Ipratropium | 0.12 mg Inhalation aerosol |
0.12 mg Inhalation powder |
||
0.3 mg Inhalation solution |
||
| Long–acting anti–cholinergics | Tiotropium bromide | 18 mcg Inhalation powder |
| Cromones | Cromoglycate | 40 mg Inhalation aerosol |
80 mg Inhalation powder |
||
80 mg Inhalation solution |
||
| Nedocromil | 8 mg Inhalation aerosol |
|
| Inhaled corticosteroids | Beclomethasone | 0.8 mg Inhalation aerosol |
0.8 mg Inhalation powder |
||
1.5 mg Inhalation solutio |
||
| Budesonide | 0.8 mg Inhalation aerosol |
|
0.8 mg Inhalation powder |
||
1.5 mg Inhalation solution |
||
| Fluticasone | 0.6 mg Inhalation aerosol |
|
0.6 mg Inhalation powder |
||
1.5 mg Inhalation solution |
||
| Xanithines | Theophylline | 0.4 g Oral |
| Choline theophyllinate | 0.6 g Oral |
|
| Leukotriene receptor antagonists | Montelukast | 10 mg Oral |
| Zafirlukast | 40 mg Oral |
Note: DDD = defined daily dose
<< Return to Table of Contents >>
© Australian Institute of Health and Welfare 2008